Search

everythinglearnresearchcommunity

for

Search:↓

More men are getting cosmetic surgery, with nose jobs and hair transplants being popular, and choosing a qualified surgeon is important.

Male pattern baldness is a common hair loss in men caused by genetics and hormones, with treatments including drugs, hair transplants, and hair loss products.

Light therapy might help treat hereditary hair loss by improving hair follicle growth in lab cultures.

Different treatments for Hidradenitis suppurativa range from antibiotics and hormonal therapies to surgery, depending on severity.

Platelet-rich plasma can increase hair density and may help treat some skin conditions, but it's costly, not FDA-approved, and needs more research.

Gender-affirming dermatology treatments generally improve mental well-being for transgender individuals, but more research is needed.

Tofacitinib helped regrow hair in people with severe alopecia, but side effects occurred and benefits stopped after treatment ended.

Latanoprostene bunod effectively lowers eye pressure and is better tolerated than other glaucoma medications.

Hormone therapy in transgender women can affect hair growth and acne, and there are specific skin issues related to gender-affirming surgery, but more research is needed on their dermatological health.

Transgender and nonbinary individuals experience hair loss, with transmen on testosterone seeing more severe hair loss, while feminizing hormones may stabilize hair loss in transwomen.

Estheticians in dermatology improve patient satisfaction and loyalty with proper training and planning.

The guideline recommends mental health involvement in diagnosing gender identity disorder and outlines hormone and surgical treatment protocols, emphasizing safety, informed consent, and long-term monitoring.

Manage vitiligo with treatments, address emotions, and use camouflage techniques.

The document likely offers guidance on treating a woman's excessive hair growth, considering her symptoms and obesity.

The document concludes that proper diagnosis and a multidisciplinary approach are crucial for managing Congenital Adrenal Hyperplasia effectively.

Oral tofacitinib can significantly improve recalcitrant lichen planopilaris.

The document concludes that early recognition and treatment of PCOS in adolescents is crucial for managing symptoms and long-term health risks.

High-frequency ultrasonography is a useful but underused tool in dermatology for assessing skin cancers, monitoring diseases, and evaluating treatments.

Scalp cooling can reduce chemotherapy-induced hair loss and should be available in all hospitals.

Patients with PCOS rate their hirsutism higher than clinicians, and these self-ratings are more closely related to their quality of life and risk of depression.

People often struggle to consistently use contraceptives and other medications, and long-acting options might be better for those who want to avoid daily doses.

LGBT individuals have unique skin health needs, including higher STD risks and side effects from gender-affirming treatments, requiring dermatologists to offer knowledgeable and culturally competent care.

Injectables can feminize or masculinize a transgender person's face, but more research is needed for best practices.

Improved dermabrasion techniques in 1987 led to better treatment results for skin issues like acne scars.

Doctors should know how to diagnose and treat PCOS, which often involves checking for high male hormone levels and using medications to manage symptoms.

In Brazil in 2018, the most common skin issues were acne, photoaging, and nonmelanoma skin cancer, with treatments often including topical medications and sunscreen.

Dermatologists perform most outpatient cosmetic procedures in the U.S., especially on white women aged 40 to 59.

The document concludes that freeze-dried platelet-rich plasma shows promise for medical use but requires standardization and further research.

Dermatologists performed the most outpatient cosmetic procedures in the U.S. from 1995 to 2003, especially on white women aged 40 to 59.

Cross-sex hormone therapy is important for managing gender dysphoria and requires careful monitoring and healthcare provider education.